Back
BYD Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
77
BYDDF
BYD
Last Price:
$52.00
Seasonality Move:
10.94%
Buy
66
SRPT
Sarepta Therapeutics
Last Price:
$60.45
Seasonality Move:
13.61%
Buy
66
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $61.76. The Score for SRPT is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BYDDF Stock Price Chart
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $61.76Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
BYDDF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.67 | Buy |
Relative Strength Index (14 RSI): | 60.04 | Buy |
Chaikin Money Flow: | -48955 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.1 - 51.78) | Buy |
Bollinger Bands (100): | (34.21 - 48.73) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.72 | Sell |
Relative Strength Index (14 RSI): | 44.97 | Sell |
Chaikin Money Flow: | 1413454 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
BYDDF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.67 | Buy |
20-day SMA: | 47.6 | Buy |
50-day SMA: | 48.18 | Buy |
200-day SMA: | 36.97 | Buy |
8-day EMA: | 49.39 | Buy |
20-day EMA: | 48.38 | Buy |
50-day EMA: | 46.58 | Buy |
200-day EMA: | 38.83 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.57 | Buy |
20-day SMA: | 57.74 | Buy |
50-day SMA: | 81.94 | Sell |
200-day SMA: | 116.58 | Sell |
8-day EMA: | 57.69 | Buy |
20-day EMA: | 61.26 | Buy |
50-day EMA: | 77.18 | Sell |
200-day EMA: | 106.29 | Sell |
BYD Earnings Growth & BYDDF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.28 per share, a decrease next quarter of $0.51 per share, an increase this year of $3.58 per share, and an increase next year of $6.23 per share.
BYD Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |